{"log_id": 2056964110351458401, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 0.004271, "average": 0.986404, "min": 0.596448}, "location": {"width": 746, "top": 287, "height": 34, "left": 248}, "words": "病理改变,既有白质(水肿),也有灰质(分散的变软的条纹区)。实验室检查指材"}, {"probability": {"variance": 0.001679, "average": 0.990693, "min": 0.748918}, "location": {"width": 754, "top": 322, "height": 33, "left": 250}, "words": "中仅脑脊液的GOT(谷草转氨酶)活性升高,发生在给以中剂量和高剂量药物的"}, {"probability": {"variance": 3.9e-05, "average": 0.995189, "min": 0.982937}, "location": {"width": 107, "top": 362, "height": 25, "left": 253}, "words": "雄性动物中"}, {"probability": {"variance": 3e-06, "average": 0.997788, "min": 0.995233}, "location": {"width": 87, "top": 428, "height": 26, "left": 171}, "words": "生殖毒性"}, {"probability": {"variance": 0.007911, "average": 0.97448, "min": 0.503235}, "location": {"width": 755, "top": 452, "height": 36, "left": 252}, "words": "用大量的雌雄大鼠进行了多个生育和胚胎毒性的实验。分别在受孕前、受孕后和"}, {"probability": {"variance": 0.006595, "average": 0.97842, "min": 0.556613}, "location": {"width": 744, "top": 489, "height": 31, "left": 253}, "words": "持续至胚胎形成期结束以及分娩店第21天连续静脉给予碘帕醇;剂量分别为0:3"}, {"probability": {"variance": 0.00614, "average": 0.966107, "min": 0.642316}, "location": {"width": 754, "top": 519, "height": 37, "left": 252}, "words": "06,1.5和4g(碘)水kg并设对照组。实验覆盖所有时期,以观察碘帕醇对卵子"}, {"probability": {"variance": 0.001013, "average": 0.990784, "min": 0.827615}, "location": {"width": 756, "top": 556, "height": 29, "left": 254}, "words": "发生、排卵作用发情周期和哺乳期有何影响。实验结果表明:即使在剂量为4g"}, {"probability": {"variance": 0.000538, "average": 0.991993, "min": 0.892235}, "location": {"width": 730, "top": 587, "height": 33, "left": 276}, "words": "碘)/kg,可以引起雌、雄大鼠表现出中毒症状时,仍不影响生殖功能对胚胎"}, {"probability": {"variance": 8e-06, "average": 0.997636, "min": 0.990952}, "location": {"width": 424, "top": 623, "height": 30, "left": 254}, "words": "没有毒性。没有引起任何围产期或者产后变化"}, {"probability": {"variance": 1.9e-05, "average": 0.996664, "min": 0.989392}, "location": {"width": 90, "top": 690, "height": 26, "left": 173}, "words": "遗传毒性"}, {"probability": {"variance": 0.007267, "average": 0.977587, "min": 0.542866}, "location": {"width": 754, "top": 715, "height": 36, "left": 254}, "words": "碘帕醇的致突变能力通过检测回复突变能力:检测基因移位x检测正向突变等实验"}, {"probability": {"variance": 0.00265, "average": 0.983431, "min": 0.705977}, "location": {"width": 753, "top": 751, "height": 29, "left": 255}, "words": "进行评价。实验结果表明:无论是否经过代谢活化,碘帕醇都不能使基因回复或移"}, {"probability": {"variance": 0.002844, "average": 0.982183, "min": 0.759906}, "location": {"width": 752, "top": 784, "height": 30, "left": 256}, "words": "位的发生频率显著升高。不论是体内或者体外,都不能使正向突变的发生频率显著"}, {"probability": {"variance": 7e-06, "average": 0.997805, "min": 0.988358}, "location": {"width": 445, "top": 819, "height": 30, "left": 255}, "words": "升高,因为所有的致突变能力检测结果均为阴性"}, {"probability": {"variance": 2e-06, "average": 0.998371, "min": 0.996264}, "location": {"width": 69, "top": 886, "height": 25, "left": 174}, "words": "致癌性"}, {"probability": {"variance": 0.000988, "average": 0.990037, "min": 0.818723}, "location": {"width": 754, "top": 913, "height": 33, "left": 257}, "words": "碘帕醇的结构不与任何已知的致癌物的结构类似,而且临床上只使用1次,因此未"}, {"probability": {"variance": 1e-06, "average": 0.998881, "min": 0.996495}, "location": {"width": 149, "top": 952, "height": 25, "left": 257}, "words": "对其行致癌实验"}, {"probability": {"variance": 1e-06, "average": 0.998936, "min": 0.996535}, "location": {"width": 136, "top": 1016, "height": 25, "left": 182}, "words": "【药代动力学】"}, {"probability": {"variance": 0.00046, "average": 0.994429, "min": 0.865084}, "location": {"width": 792, "top": 1044, "height": 33, "left": 218}, "words": "本品具有高度水溶性,低血浆蛋白结合等特点,几乎只分布于细胞外,没有或仅有少量"}, {"probability": {"variance": 0.020804, "average": 0.949163, "min": 0.395052}, "location": {"width": 795, "top": 1077, "height": 32, "left": 218}, "words": "分布于细胞内。此物质主要以原形通过肾脏清除(9%在收集2-96小时的粪便标"}, {"probability": {"variance": 0.007062, "average": 0.981227, "min": 0.481196}, "location": {"width": 795, "top": 1113, "height": 28, "left": 219}, "words": "本中仅含有1%或更少的碘帕醇。如果肾功能正常给药以后.60分钟时,碘帕醇尿排"}, {"probability": {"variance": 0.005182, "average": 0.977405, "min": 0.546481}, "location": {"width": 754, "top": 1145, "height": 30, "left": 218}, "words": "泄为35-40%。在8小时时排泄率为80-90%,在7296小时时排泄率为90%或更多"}, {"probability": {"variance": 0.000897, "average": 0.99324, "min": 0.813343}, "location": {"width": 797, "top": 1205, "height": 37, "left": 217}, "words": "静脉注射后,碘帕醇通过肾小球过滤排泄,其清除过程与肌酐相似,因此对于老年病人"}, {"probability": {"variance": 8.1e-05, "average": 0.996431, "min": 0.963401}, "location": {"width": 503, "top": 1240, "height": 36, "left": 219}, "words": "或肾功能损害病人,与正常病人相比其清除速率稍低"}, {"probability": {"variance": 0.000146, "average": 0.995751, "min": 0.927272}, "location": {"width": 795, "top": 1306, "height": 33, "left": 218}, "words": "椎管内注射后,碘帕醇极易与脑脊液混合,且不与脑脊液蛋白结合,能够被快速、完全"}, {"probability": {"variance": 2e-05, "average": 0.998068, "min": 0.975433}, "location": {"width": 790, "top": 1338, "height": 35, "left": 219}, "words": "地从脑脊液吸收入血浆,再通过肾脏排出体外。临床试验显示:椎管内注射后24小时"}, {"probability": {"variance": 1e-06, "average": 0.998829, "min": 0.996094}, "location": {"width": 191, "top": 1377, "height": 27, "left": 220}, "words": "未能从脑脊液中检出"}, {"probability": {"variance": 0, "average": 0.999859, "min": 0.999626}, "location": {"width": 73, "top": 1441, "height": 25, "left": 187}, "words": "【贮藏】"}, {"probability": {"variance": 0.016805, "average": 0.933293, "min": 0.636805}, "location": {"width": 176, "top": 1475, "height": 25, "left": 180}, "words": "30°C以下避光保存"}, {"probability": {"variance": 0, "average": 0.999917, "min": 0.999895}, "location": {"width": 74, "top": 1537, "height": 25, "left": 184}, "words": "【包装】"}, {"probability": {"variance": 0.003053, "average": 0.975239, "min": 0.812386}, "location": {"width": 162, "top": 1572, "height": 24, "left": 178}, "words": "玻璃瓶瓦,10瓶/盒"}], "language": 3}